• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Debt

Hayfin markets USD 500m healthcare-focused private credit fund

  • Josh O'Neill and Maryna Irkliyenko
  • 27 February 2023
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Hayfin is raising a dedicated private debt fund that will focus solely on credit investments in the healthcare sector, four sources familiar with the situation told sister publication Debtwire.

The direct lender is seeking to raise around USD 500m for the fund, which has already held its first close, according to the first and second sources.

The vehicle, which is thought to be one of the first of its kind, will be distinct from Hayfin’s direct lending and special opportunities funds, through which it has historically made direct loans to private and public healthcare companies, the first source said.

Through its new healthcare-focused fund, Hayfin will be able to target opportunities that do not necessarily fit within its existing private debt strategies, the second source continued. Investments could include ARR-based direct loans to cashflow-negative, high-growth healthcare companies, the second source added.

The fund will have a transatlantic investment mandate, enabling Hayfin to make direct loans to European and US-based healthcare companies, the first source said.

Hayfin typically gravitates towards credit opportunities within healthcare products and services, including pharmaceuticals and generics, medical devices, business-to-business solutions and services, contract manufacturing, and research, the second source pointed out. Companies operating in these sub-verticals tend to showcase higher gross margins and revenue durability, therefore providing stronger underwriting conviction, this source explained.

Around a quarter of Hayfin’s private credit investments have been deployed into healthcare companies, the second source said. Hayfin employs at least nine staff in the UK and US who focus solely on healthcare credit investments, this source added.

In addition to its healthcare-focused private credit fund, Hayfin is seeking to raise around EUR 6bn for its fourth flagship direct lending fund, according to a report published in December by Bloomberg.

Founded in 2009, Hayfin’s strategies span direct lending, special opportunities and high-yield credit. The asset manager has deployed more than EUR 35bn across 470 companies, according to its website.

Hayfin declined to comment.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Debt
  • Credit/Special Situations
  • Healthcare
  • UK / Ireland
  • Benelux
  • CEE
  • DACH
  • Southern Europe
  • Nordics
  • France
  • Hayfin Capital Management

More on Debt

Direct lending funds
Hayfin exceeds EUR 6bn target for fourth direct lending fund

Firm expects to raise EUR 7bn by year-end as it gears up to meet growing private credit demand in Europe

  • Fundraising
  • 18 August 2023
Direct lending fundraise
Morgan Stanley nears EUR 1.6bn-plus first close for maiden European direct lending fund

Investment manager started marketing fund to LPs last year; expects to raise in excess of EUR 3bn

  • Debt
  • 18 August 2023
Direct lending funds
Arcmont eyes up to EUR 10bn in new money for European direct lending strategy

Fresh fundraise would be a significant step up from its previous EUR 6bn European direct lending fund

  • Debt
  • 09 August 2023
Paris's Arc de Triomphe
Eurazeo co-CEOs seek to reassure market following key departures

Listed GP is also considering options for its stake in Spanish PE platform MCH, it said in its latest results

  • GPs
  • 28 July 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013